Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
Tang
J
J
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. jtang@uab.edu
Kaslow
R A
RA
D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus / Q000187:drug effects / Q000254:growth & development; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods*
D000998:Antiviral Agents